Skip to main content
. 2017 Aug 4;12:2313–2321. doi: 10.2147/COPD.S142621

Table 2.

Comparison of clinical characteristics between non-COPD and COPD subjects

Variables Male (n=1,179)
Female (n=387)
Non-COPD
n=597
COPD
n=582
P-value Non-COPD
n=188
COPD
n=199
P-value
Age, years 64.5±9.3 65.0±9.1 0.325 66.0±9.3 65.6±9.0 0.653
Age category, years
 40–49 50 (8.4) 42 (7.2) 0.554 12 (6.4) 10 (5.0) 0.818
 50–59 124 (20.8) 110 (18.9) 30 (16) 38 (19.1)
 60–69 248 (41.5) 240 (41.2) 78 (41.5) 79 (39.7)
 ≥70 175 (29.3) 190 (32.6) 68 (36.2) 72 (36.2)
Smoking status
 Never 136 (22.8) 76 (13.1) <0.001 176 (93.6) 183 (92) 0.704
 Ex-smoker 328 (54.9) 298 (51.2) 8 (4.3) 9 (4.5)
 Current 133 (22.3) 208 (35.7) 4 (2.1) 7 (3.5)
Anemia 55 (9.6) 34 (6.1) 0.039 17 (9.6) 17 (9.2) 0.905
HGS, kg 38.0±7.0 38.9±7.0 0.044 23.8±4.6 24.2±4.9 0.342
FEV1 % of predicted value 95.3±12.5 79.5±14.7 <0.001 98.3±12.9 80.0±17.6 <0.001
GOLD stage
 GOLD I 300 (51.5) 102 (51.3)
 GOLD II 261 (44.8) 86 (43.2)
 GOLD III, IV 21 (3.6) 11 (5.5)

Note: Data represented as mean ± SD or n (%).

Abbreviations: COPD, chronic obstructive pulmonary disease; SD, standard deviation; HGS, hand grip strength; FEV1, forced expiratory volume in 1 second; GOLD, Global Initiative for Chronic Obstructive Lung Disease.